Revenue
2016
2017
2018
2019
2020
2021
2022
2023
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.23B | $29.45B | $28.95B | $26.13B | $27.98B | $27.66B | $25.20B | $24.93B | $35.48B | $39.83B | $41.85B | $39.34B | $37.99B | $31.59B | $31.80B | $34.91B | $29.18B |
| Gross profit | $11.21B | $9.71B | $9.47B | $7.88B | $8.91B | $8.54B | $7.85B | $7.53B | $10.13B | $11.21B | $11.99B | $11.38B | $11.43B | $9.53B | $9.32B | $10.94B | $8.97B |
| Research & development | $1.32B | $1.17B | $1.22B | $1.13B | $1.20B | $1.15B | $1.01B | $967.0M | $1.41B | $1.50B | $1.47B | $1.46B | $1.37B | $1.08B | $1.04B | $1.03B | — |
| Operating income | $4.87B | $3.34B | $5.72B | $1.59B | $1.94B | $2.23B | $2.23B | $1.93B | $3.05B | $4.18B | $4.39B | $4.06B | $4.67B | $3.82B | $4.13B | $4.55B | $4.02B |
| EBITDAderived | $5.65B | $4.15B | $6.61B | $2.51B | $2.90B | $3.14B | $3.07B | $2.80B | $4.21B | $5.48B | $5.71B | $5.24B | $5.66B | $4.52B | $4.78B | $5.21B | $4.63B |
| Net income | $3.82B | $2.59B | $4.65B | $5.21B | $1.53B | $2.30B | $2.37B | $2.03B | $2.06B | $2.72B | $2.91B | $2.81B | $3.31B | $2.56B | $2.90B | $3.12B | $3.61B |
| Basic EPSper diluted share | $2.02 | $1.30 | $2.27 | $2.44 | $0.67 | $1.02 | $1.04 | $0.88 | $0.87 | $1.13 | $1.21 | $1.18 | $1.38 | $1.12 | $1.27 | $1.36 | $1.60 |
| Diluted EPSper diluted share | $2.01 | $1.30 | $2.25 | $2.43 | $0.67 | $1.02 | $1.03 | $0.88 | $0.87 | $1.13 | $1.21 | $1.18 | $1.38 | $1.12 | $1.27 | $1.36 | $1.57 |